Winfield Associates’s Chemed CHE Stock Holding History

Winfield Associates’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40	Closed	-$8K	–	802
2017 Q2	$8K	Buy	+40	New	+$7.97K	﹤0.01%	431

Other funds holding CHE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Winfield Associates's CHE Position: Q3 2017 in Review

Winfield Associates sold out of Chemed (CHE) in Q3 2017, closing a stake of 40 shares — an estimated $8K sold.

Winfield Associates first reported a position in CHE in Q2 2017 and held it in 1 quarter. The position peaked at $8K in Q2 2017. 259 funds tracked by Wall St. Rank hold CHE as of Q3 2017.

Winfield Associates reported no remaining Chemed position as of Q3 2017 after selling out during the quarter.
Winfield Associates sold 40 Chemed shares in Q3 2017, an estimated $8K.
Winfield Associates first reported a position in Chemed in Q2 2017 and held it in 1 quarter.
Winfield Associates's Chemed position peaked at $8K in Q2 2017.
259 funds tracked by Wall St. Rank held Chemed as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.